Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Items (Tables)

v3.20.1
Composition of Certain Financial Statement Items (Tables)
6 Months Ended
Mar. 29, 2020
Balance Sheet Related Disclosures [Abstract]  
Inventories
Inventories (in millions)
March 29,
2020
September 29,
2019
Raw materials $ 101    $ 77   
Work-in-process 802    667   
Finished goods 797    656   
$ 1,700    $ 1,400   
Equity Securities without Readily Determinable Fair Value The carrying values of our equity method and non-marketable equity investments are recorded in other noncurrent assets and were as follows (in millions):
March 29,
2020
September 29,
2019
Equity method investments $ 210    $ 343   
Non-marketable equity investments 726    787   
$ 936    $ 1,130   
Schedule of Short-term Debt
Short-term Debt (in millions)
March 29,
2020
September 29,
2019
Commercial paper $ 499    $ 499   
Current portion of long-term debt 2,000    1,997   
$ 2,499    $ 2,496   
Investment and Other Income, Net
Investment and Other (Expense) Income, Net (in millions)
Three Months Ended Six Months Ended
March 29,
2020
March 31,
2019
March 29,
2020
March 31,
2019
Interest and dividend income $ 47    $ 78    $ 107    $ 143   
Net gains (losses) on marketable securities 55      66    (19)  
Net (losses) gains on other investments (12)     36    42   
Net (losses) gains on deferred compensation plan assets (72)   37    (42)   (2)  
Impairment losses on other investments (265)   (60)   (337)   (69)  
Net (losses) gains on derivative investments —    (1)     (9)  
Equity in net losses of investees (6)   (36)   (16)   (58)  
Net gains (losses) on foreign currency transactions   (1)      
$ (247)   $ 28    $ (182)   $ 33